| Project Detail |
In situ oral disinfection with plasma technology
Oral hygiene is important not only for aesthetic reasons but also for overall health as gum disease and subsequent inflammation have been linked to heart and kidney disease. Funded by the European Innovation Council, the AmbiJet project is introducing a proprietary technology that permits in situ disinfection of and around dental implants. The solution is based on plasma technology, has no side effects, and demonstrates superior effectiveness to current treatment options. Furthermore, it reduces the chance of re-infection, sparing further patient suffering.
Regular dental check-ups and treatments not only ensure a beautiful smile, but good general health: a healthy oral cavity strengthens the immune system and acts as a barrier against various heart-, kidney-, or lungs-related diseases and diabetes. There is currently no effective solution to treat the 16.3 mn infected dental implants (EU, 2019). Freiburger Medizintechnik GmbH developed the solution dentists are looking for: a disruptive technology for highly effective infection control to fight periimplantitis. AmbiJet® is the world’s first and only plasma-based technology with the ability to kill bacteria on dental implants in-situ. It disrupts the status-quo of medical technologies by preventing the reinfection of disinfected surfaces and shows maximum effectiveness without side nor adverse effects: pharmacological and chemical substances are no longer required. AmbiJet® reduces inflammation, saves dental implants and helps patients live a healthier life. |
